The enterohepatic perturbation of bile acids resulted in reduced signaling via TGR5 and FXR in mice with NASH; and the restoration of TGR5 and FXR signaling by deoxycholic acid (DCA) supplementation protected from NASH and associated metabolic features [22]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.